Skip to main content
Log in

Oral contrast agents for small bowel distension in MRI: influence of the osmolarity for small bowel distention

  • Gastrointestinal
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

To assess the effect of the osmolarity for small bowel distension in MRI, ten volunteers ingested at two separate occasions negative oral contrast agents with different quantity and osmolarity: (1) a water solution combined with 2.0% sorbitol and 0.2% locus bean gum (LBG) with a quantity of 1500 ml and an osmolarity of 148 mOsmol/l, (2) a water solution combined with 2.0% sorbitol and 2.0% barium sulphate with a quantity of 1000 ml and an osmolarity of 194 mOsmol/l. Small bowel distension was quantified on coronal 2D-TrueFISP images by measuring the small bowel diameters. There were no statistically significant differences in mean small bowel diameter between both contrast agents. The mean small bowel distension was 19.2 mm after ingestion of 1500 ml of sorbitol-LBG solution and 19.0 mm after ingestion of 1000-ml sorbitol–barium sulphate solution. Furthermore, all volunteers found the ingestion of 1000-ml solution more pleasant than the 1500-ml solution. The ingestion of 1000 ml of sorbitol–barium sulphate solution led to a sufficient small bowel distension compared to 1500 ml of sorbitol–LBG solution. The side effect rate of both solutions was low. Based on these data, we recommend a quantity of 1000 ml of sorbitol–barium sulphate solution as an alternative for 1500-ml sorbitol–LBG solution for optimal bowel distension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Karlinger K, Györke T, Makö E, Mester A, Tarján Z (2000) The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 35:154–167

    Google Scholar 

  2. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Prassopoulos P (2002) MR enteroclysis: technical considerations and clinical applications. Eur Radiol 12:2651–2658

    PubMed  Google Scholar 

  3. Lauenstein TC, Schneemann H, Vogt FM, Herborn CU, Rühm SG, Debatin JF (2003) Optimization of oral contrast agents for MR imaging of the small bowel. Radiology 228:279–283

    Google Scholar 

  4. Maglinte DD, Gourtsoyiannis N, Rex D, Howard TJ, Kelvin FM (2003) Classification of small bowel Crohn’s subtypes based on multimodality imaging. Radiol Clin North Am 2:285–303

    Google Scholar 

  5. Schunk K, Kern A, Heussel CP, Kalden P, Mayer I, Orth T et al. (2000) Assessment of inflammatory activity in Crohn’s disease with hydro-MRI. RoFo Fortschr Geb Rontgenstrahlen Neuen Bildgeb Verfahr 2:153–160

    Google Scholar 

  6. Maglinte DD, Chernish SM, Kelvin FM (1992) Crohn disease of the small intestine: accuracy and relevance of enteroclysis. Radiology 184:541–545

    CAS  PubMed  Google Scholar 

  7. Maglinte DD, Hall R, Miller RE, Chernish SM, Rosenak B, Elmore M et al. (1984) Detection of surgical lesions of the small bowel by enteroclysis. Am J Surg 147:225–229

    Google Scholar 

  8. Umschaden HW, Szolar D, Gasser J, Umschaden M, Haselbach H (2000) Small-bowel disease: comparison of MR enteroclysis images with conventional enteroclysis and surgical findings. Radiology 215:717–725

    CAS  PubMed  Google Scholar 

  9. Antoch G, Kuehl H, Kanja J, Lauenstein TC, Schneemann H, Hauth E et al. (2004) Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation. Radiology 230:879–885

    PubMed  Google Scholar 

  10. Ajaj W, Goehde SC, Schneemann H, Rühm SG, Debatin JF, Lauenstein TC (2003) Oral contrast agents for small bowel MRI: comparison of different additives to optimize bowel distension. Eur Radiol 14:458–464

    Google Scholar 

  11. Nakabayashi T, Mochiki E, Kamiyama Y, Haga N, Asao T, Kuwano H (2003) Erythromycin induces pyloric relaxation accompanied by a contraction of the gastric body after pylorus-preserving gastrectomy. Surgery 133:647–655

    Google Scholar 

  12. Stacher G, Peeters TL, Bergmann H, Wiesnagrotzki S, Schneider C, Granser-Vacariu GV et al. (1993) Erythromycin effects on gastric emptying, antral motility and plasma motilin and pancreatic polypeptide concentrations in anorexia nervosa. Gut 34:166–172

    Google Scholar 

  13. Shia J, Teruya-Feldstein J, Pan D, Hegde A, Klimstra DS, Chaganti RS et al. (2002) Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 cases. Am J Surg Pathol 26:216–224

    Google Scholar 

  14. Kettritz U, Isaacs K, Warshauer DM, Semelka RC (1995) Crohn’s disease. Pilot study comparing MRI of the abdomen with clinical evaluation. J Clin Gastroenterol 3:249–253

    Google Scholar 

  15. Madsen SM, Thomsen HS, Munkholm P, Dorph S, Schlichting P (1998) Active Crohn’s disease and ulcerative colitis evaluated by low-field magnetic resonance imaging. Scand J Gastroenterol 11:1193–1200

    Google Scholar 

  16. Lomas DJ, Graves MJ (1999) Small bowel MRI using water as a contrast medium. Br J Radiol 72:994–997

    Google Scholar 

  17. Hänsel R, Sticher O, Steinegger E Pharmakognosy and phytopharmazy. Springer Verlag, Berlin Heidelberg New York

  18. Nau R, Dreyhaupt T, Kolenda H, Prange HW (1992) Low blood-to-cerebrospinal fluid passage of sorbitol after intravenous infusion. Stroke 23:1276–1279

    Google Scholar 

  19. Hubbell JH (1982) Photon mass attenuation and energy-absorption coefficients from 1 keV to 20 MeV. Int J Appl Radiat Isot 33:1269–1290

    Google Scholar 

  20. Reimund JM, Jung-Chaigneau E, Chamouard P, Wittersheim C, Duclos B, Baumann R (1999) Diagnostic value of high resolution sonography in Crohn’s disease and ulcerative colitis. Gastroenterol Clin Biol 7:740–746

    Google Scholar 

  21. Lim JH, Ko YT, Lee DH, Lim JW, Kim TH (1994) Sonography of inflammatory bowel disease: findings and value in differential diagnosis. AJR Am J Roentgenol 2:343–347

    Google Scholar 

  22. Lew RJ, Ginsberg GG (2002) The role of endoscopic ultrasound in inflammatory bowel disease. Gastrointest Endosc Clin N Am 3:561–571

    Google Scholar 

  23. Borthne AS, Dormagen JB, Gjesdal KI, Storaas T, Lygren I, Geitung JT (2003) Bowel MR imaging with oral gastrografin: an experimental study with healthy volunteers. Eur Radiol 13:100–106

    Google Scholar 

  24. Narin B, Ajaj W, Gohde S et al. (2004) Combined small and large bowel MR imaging in patients with Crohn’s disease: a feasibility study. Eur Radiol 14:1535–1542

    Google Scholar 

  25. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Maris T, Prassopoulos P (2001) MR enteroclysis protocol optimization: comparison between 3D FLASH with fat saturation after intravenous gadolinium injection and true FISP sequences. Eur Radiol 11:908–913

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Waleed Ajaj.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ajaj, W., Goyen, M., Schneemann, H. et al. Oral contrast agents for small bowel distension in MRI: influence of the osmolarity for small bowel distention. Eur Radiol 15, 1400–1406 (2005). https://doi.org/10.1007/s00330-005-2711-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-005-2711-3

Keywords

Navigation